MYCN and neuroblastoma: Among several cancer-related genomic alterations, MYCN gene amplification, leading to MYCN protein overexpression, has been found in about 20% to 25% of NB cases [17,18], and is associated with increasing disease severity, rapid progression and poor disease outcome [19].